With nearly $3.0B raised, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.
Pharma Packager PCI Sells for More Than $1 Billion
Providence Service Corporation and Frazier Healthcare Partners Complete Formation of Strategic Partnership in Matrix Medical Network
Nivalis Therapeutics and Alpine Immune Sciences Agree to Combine
U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients